ARTIVA BIOTHERAPEUTICS
2.2900
16-4月-25 15:45:00
15 分の遅延
株式
-0.0600
-2.55%
本日の幅
2.1004 - 2.3492
ISIN
N/A
ソース
NASDAQ
-
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
08 4 2025 15:05:00 提供 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
31 3 2025 15:05:00 提供 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
24 3 2025 15:05:00 提供 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
20 2 2025 15:05:00 提供 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.
29 1 2025 15:05:00 提供 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
12 11 2024 15:05:01 提供 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
11 11 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
22 10 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
10 9 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
29 8 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
18 7 2024 18:08:52 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >